Present and future roles of FDG-PET/CT imaging in the management of lung cancer

Integrated positron emission tomography/computed tomography (PET/CT) using 2-[ 18 F]fluoro-2-deoxy- d -glucose ( 18 F-FDG) has emerged as a powerful tool for combined metabolic and anatomic evaluation in clinical oncologic imaging. This review discusses the utility of 18 F-FDG PET/CT as a tool for m...

Full description

Saved in:
Bibliographic Details
Published in:Japanese Journal of Radiology 2016-06, Vol.34 (6), p.387-399
Main Authors: Kitajima, Kazuhiro, Doi, Hiroshi, Kanda, Tomonori, Yamane, Tomohiko, Tsujikawa, Tetsuya, Kaida, Hayato, Tamaki, Yukihisa, Kuribayashi, Kozo
Format: Article
Language:English
Subjects:
Fluorodeoxyglucose F18
Humans
Imaging
Lung - diagnostic imaging
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - pathology
Lung Neoplasms - therapy
Medicine
Medicine & Public Health
Neoplasm Staging
Nuclear Medicine
Positron Emission Tomography Computed Tomography
Radiology
Radiopharmaceuticals
Radiotherapy
Radiotherapy Planning, Computer-Assisted - methods
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Integrated positron emission tomography/computed tomography (PET/CT) using 2-[ 18 F]fluoro-2-deoxy- d -glucose ( 18 F-FDG) has emerged as a powerful tool for combined metabolic and anatomic evaluation in clinical oncologic imaging. This review discusses the utility of 18 F-FDG PET/CT as a tool for managing patients with lung cancer. We discuss different patient management stages, including diagnosis, initial staging, therapy planning, early treatment response assessment, re-staging, and prognosis.
ISSN:1867-1071
1867-108X
DOI:10.1007/s11604-016-0546-2